News Articles February 2022
Ohio State Opens New Cancer Trials
Dozens of new cancer trials are now open at the Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James). If you would like more information or are interested in referring a patient to one of these trials, call The James Line at 1-800-293-5066. To search all cancer clinical trials available at the OSUCCC – James, visit cancer.osu.edu
Pituitary Journey: Diagnosing Cushing's
A column by Brandy Moody in Cushing’s Disease News recounts her six-month process, with multiple tests, an MRI and inferior petrosal sinus sampling that led to a diagnosis. Read more here:
Dr. Fred Gentili: In Memoriam
The PNA would like to offer our condolences to the family and friends of Dr. Fred Gentili, a well- respected pituitary neurosurgeon in Toronto, Canada, and a longtime member of the the PNA. Dr. Gentili was a professor in the Department of Surgery at the University of Toronto. He served as the first Director of the Skull Base Centre at the University of Toronto and was a founding member of the North American Skull Base Society. Read more here:
FDA Declines to Approve Pfizer’s Once-Weekly Drug for Pediatric GH Deficiency
Reuters reports that the U.S. Food and Drug Administration has turned down Pfizer’s application to approve a once-weekly drug called Somatrogon to combat growth hormone deficiency in children. Read more here:
However the same drug was just approved in Japan. Read more here:
Hypothyroidism and Insomnia
An article in Medical News Today looks at the link between low thyroid levels and subclinical insomnia. Often doctors associate sleeplessness with over-active thyroid, but some research suggests it can occur in patients with under-active thyroid. Read more:
Oral Octreotide Found Effective Against Acromegaly For 62 Weeks
An article in Healio reports on the results of the MPOWERED trial, which found that a 26-week course of oral octreotide worked to control acromegaly in almost all people after 62 weeks. Read more: